CPIX Key Statistics, Chart & Performance
The current stock price of CPIX is 5.15 USD. In the past month the price increased by 97.49%. In the past year, price increased by 102.57%.
CPIX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 50 | 1.04T | ||
| JNJ | JOHNSON & JOHNSON | 19.91 | 498.00B | ||
| MRK | MERCK & CO. INC. | 12.32 | 269.42B | ||
| PFE | PFIZER INC | 7.86 | 143.02B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 8.54 | 114.09B | ||
| ZTS | ZOETIS INC | 19.96 | 55.77B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.96 | 23.63B | ||
| VTRS | VIATRIS INC | 5.35 | 14.35B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.9 | 11.40B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.50B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.69B | ||
| CRNX | CRINETICS PHARMACEUTICALS IN | N/A | 5.00B |
Related stock screener links
About CPIX
Company Profile
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 91 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Company Info
CUMBERLAND PHARMACEUTICALS
1600 West End Avenue, Suite 1300
Nashville TENNESSEE 37203 US
CEO: A. J. Kazimi
Employees: 91
Phone: 18774842700
CUMBERLAND PHARMACEUTICALS / CPIX FAQ
Can you describe the business of CUMBERLAND PHARMACEUTICALS?
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The company is headquartered in Nashville, Tennessee and currently employs 91 full-time employees. The company went IPO on 2009-08-11. The firm is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) injection, for the treatment of pain and fever; Kristalose (lactulose) for oral solution, a prescription laxative, for the treatment of constipation; Sancuso (granisetron) transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ (telavancin) injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Can you provide the latest stock price for CUMBERLAND PHARMACEUTICALS?
The current stock price of CPIX is 5.15 USD. The price increased by 9.11% in the last trading session.
Does CUMBERLAND PHARMACEUTICALS pay dividends?
CPIX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CPIX stock?
CPIX has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the sector and industry classification for CUMBERLAND PHARMACEUTICALS?
CUMBERLAND PHARMACEUTICALS (CPIX) operates in the Health Care sector and the Pharmaceuticals industry.
What is CUMBERLAND PHARMACEUTICALS worth?
CUMBERLAND PHARMACEUTICALS (CPIX) has a market capitalization of 77.04M USD. This makes CPIX a Micro Cap stock.
Can you provide the upcoming earnings date for CUMBERLAND PHARMACEUTICALS?
CUMBERLAND PHARMACEUTICALS (CPIX) will report earnings on 2026-03-02.
CPIX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to CPIX. When comparing the yearly performance of all stocks, CPIX is one of the better performing stocks in the market, outperforming 95.04% of all stocks.
CPIX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CPIX. The financial health of CPIX is average, but there are quite some concerns on its profitability.
CPIX Financial Highlights
Over the last trailing twelve months CPIX reported a non-GAAP Earnings per Share(EPS) of 0.1. The EPS increased by 158.82% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -5.05% | ||
| ROE | -12.74% | ||
| Debt/Equity | 0.2 |